The effect of diabetes education tailored to nurses in psychiatry

The effectiveness of Diabetes Education tailored to nurses in PSYchiatry (DEPSY): a pragmatic non-randomised controlled cluster study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN15523920

Enrollment

120

Registered

2019-10-02

Start date

2018-08-30

Completion date

Unknown

Last updated

2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes and severe mental illness Nutritional, Metabolic, Endocrine Diabetes mellitus

Interventions

The intervention is a 3-day diabetes education tailored to psychiatric nurses in psychiatric outpatient clinics. The diabetes education is provided to all nurses employed at four psychiatric outpatien

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Individuals diagnosed with diabetes and severe mental illness 2. Treated in one of the eight psychiatric outpatient clinics in the recruitment period 3. Aged >=18 years

Exclusion criteria

Exclusion criteria: 1. Patients without diabetes 2. Patients not in the psychiatric outpatient clinics 3. Patients who do not wish to participate

Design outcomes

Primary

Measure	Time frame
1. Number of measurements and change in HbA1c levels collected two years prior to the intervention (baseline) and every 6 months 2 years after the intervention 2. Patient-reported outcomes measured in questionnaires collected one time before the intervention (baseline) and once every 6 months 2 years after the intervention. The patient-reported outcomes are based on the following scales SDSCA, PAID5, DAWN2 (tailored to people with both severe mental illness and diabetes), PACIC (tailored to people with both severe mental illness and diabetes), CARE (tailored to people with both severe mental illness and diabetes), WHO5 and SF36 and two new questions has been developed for the present study: On a scale from 1 to 10 how much does diabetes impact your everyday life? How relevant is it to receive diabetes-related support from your psychiatric nurse from the psychiatric outpatient clinic?	—

Measure

Time frame

1. Number of measurements and change in HbA1c levels collected two years prior to the intervention (baseline) and every 6 months 2 years after the intervention 2. Patient-reported outcomes measured in questionnaires collected one time before the intervention (baseline) and once every 6 months 2 years after the intervention. The patient-reported outcomes are based on the following scales SDSCA, PAID5, DAWN2 (tailored to people with both severe mental illness and diabetes), PACIC (tailored to people with both severe mental illness and diabetes), CARE (tailored to people with both severe mental illness and diabetes), WHO5 and SF36 and two new questions has been developed for the present study: On a scale from 1 to 10 how much does diabetes impact your everyday life? How relevant is it to receive diabetes-related support from your psychiatric nurse from the psychiatric outpatient clinic?

—

Secondary

Measure	Time frame
Measured two years before the intervention and every 6 months 2 years after the intervention: 1. Change in number of measured lipids, urine albumin /creatinine ratio, blood pressure, weight and BMI collected from electronic patient journals 2. Change in levels of lipids, urine albumin/creatinine ratio, blood pressure, weight and BMI collected from electronic patient journals 3. Change in number of prescriptions on diabetes-related medicine (glucose-, lipids and blood pressure lowering medicine) collected from electronic patient journals 4. Change in proportion of patients screened for diabetes complications collected based on questionnaires	—

Measure

Time frame

Measured two years before the intervention and every 6 months 2 years after the intervention: 1. Change in number of measured lipids, urine albumin /creatinine ratio, blood pressure, weight and BMI collected from electronic patient journals 2. Change in levels of lipids, urine albumin/creatinine ratio, blood pressure, weight and BMI collected from electronic patient journals 3. Change in number of prescriptions on diabetes-related medicine (glucose-, lipids and blood pressure lowering medicine) collected from electronic patient journals 4. Change in proportion of patients screened for diabetes complications collected based on questionnaires

—

Countries

Denmark

Contacts

Public ContactLenette Knudsen

lenette.knudsen@regionh.dk+45 (0)61396888

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 6, 2026